Chapter 23: Case Study for the Implementation and Utilization of a Technology Platform for Sterile-Grade Filtration
- 77 Downloads
Sterile-grade filtration is a key unit operation during processing of biotherapeutics. However, selecting the optimal filter type and configuration could be a challenging task. Here we present a case study of a systematic risk-based approach for establishing a sterile filtration technology platform following Quality by Design. Since a technology platform can be considered an ideal form of prior knowledge, it is discussed how it can be leveraged to justify a reduced product-specific testing for future molecules.
KeywordsProtein sterile-grade filtration Technology platform Prior knowledge Quality by Design Biotherapeutics Protein formulation
- 1.CMC Biotech Working Group. A-Mab: a case study in bioprocess development. Version 2.1, 30 Oct 2009; 2009.Google Scholar
- 2.International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH harmonized tripartite guideline: pharmaceutical development Q8(R2); 2009. Available at: https://www.ich.org/products/guidelines/quality/article/quality-guidelines.html.
- 4.FDA Pharmaceutical cGMP. Guidance for industry: sterile drug products produced by aseptic processing — Current good manufacturing practice; September, 2004.Google Scholar
- 5.European Pharmacopeia, Ph.Eur. 9.0.Google Scholar
- 6.Badmington F, Wilkins R, Payne M, Honig ES. Vmax testing for practical microfiltration train scale-up in biopharmaceutical processing. Pharm Technol. 1995;19:64–76. Reprint RP576.Google Scholar
- 7.Decedue CJ, Unruh WP. Detection and measurements of particles in water prepared for HPLC. Biotech. 1984;2(2):78–81.Google Scholar
- 8.Meltzer TH. An investigation of membrane cartridge shedding. Transactions Sixth Annual Semiconductor Pure Water Conference, Santa Clara, CA, pp. 221–9; 1987.Google Scholar
- 13.Code of Federal Regulations, CFR 21, part 211.65.Google Scholar